Retirement Guys Formula LLC Boosts Stake in The Clorox Company (NYSE:CLX)

Retirement Guys Formula LLC raised its position in shares of The Clorox Company (NYSE:CLXFree Report) by 7.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 5,061 shares of the company’s stock after acquiring an additional 356 shares during the period. Retirement Guys Formula LLC’s holdings in Clorox were worth $825,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently modified their holdings of CLX. GoalVest Advisory LLC acquired a new stake in Clorox during the first quarter valued at approximately $31,000. First Foundation Advisors acquired a new stake in shares of Clorox during the 1st quarter worth approximately $31,000. Innealta Capital LLC acquired a new stake in shares of Clorox during the 2nd quarter worth approximately $30,000. Trifecta Capital Advisors LLC raised its position in shares of Clorox by 139.8% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after purchasing an additional 130 shares during the period. Finally, Quarry LP raised its position in shares of Clorox by 99.1% during the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock worth $31,000 after purchasing an additional 114 shares during the period. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Insider Activity

In related news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the sale, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at $2,229,719.92. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.51% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of equities analysts recently issued reports on CLX shares. Citigroup increased their price objective on Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a report on Friday, September 6th. Barclays increased their price objective on Clorox from $130.00 to $137.00 and gave the stock an “underweight” rating in a report on Friday, October 11th. BNP Paribas raised Clorox to a “strong sell” rating in a report on Friday, September 6th. Jefferies Financial Group raised Clorox from a “hold” rating to a “buy” rating and increased their price objective for the stock from $174.00 to $187.00 in a report on Tuesday, October 1st. Finally, Wells Fargo & Company decreased their price target on Clorox from $135.00 to $130.00 and set an “underweight” rating for the company in a research note on Wednesday, July 10th. Six analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $150.14.

View Our Latest Report on CLX

Clorox Price Performance

Shares of NYSE:CLX traded down $1.02 on Monday, reaching $160.94. 307,791 shares of the company traded hands, compared to its average volume of 1,226,097. The company’s 50 day moving average is $159.28 and its 200-day moving average is $145.14. The stock has a market capitalization of $19.99 billion, a PE ratio of 83.92, a P/E/G ratio of 3.19 and a beta of 0.41. The Clorox Company has a fifty-two week low of $114.68 and a fifty-two week high of $169.09. The company has a debt-to-equity ratio of 5.04, a current ratio of 1.03 and a quick ratio of 0.63.

Clorox (NYSE:CLXGet Free Report) last announced its quarterly earnings data on Thursday, August 1st. The company reported $1.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.28. Clorox had a return on equity of 281.12% and a net margin of 3.95%. The business had revenue of $1.90 billion during the quarter, compared to analyst estimates of $1.97 billion. As a group, analysts anticipate that The Clorox Company will post 6.64 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be given a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 3.03%. The ex-dividend date is Wednesday, October 23rd. Clorox’s dividend payout ratio is currently 252.85%.

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Read More

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.